Quantcast

Latest Meningococcal disease Stories

2012-12-18 05:02:54

This study is a Phase 3, Randomized, Placebo-Controlled, Double-Blind Trial to Assess the Safety, Tolerability and Immunogenicity of a new Meningococcal Vaccine When Given in Healthy Subjects Age 11 to 26. (PRWEB) December 17, 2012 **Avail Clinical Research is now enrolling for a Meningitis Vaccine Clinical Trial near Orlando Florida. To get started, visit Avail Clinical Research or call us directly at (386) 310-1334. Neisseria meningitidis is a leading cause of bacterial meningitis in...


Latest Meningococcal disease Reference Libraries

72_d0e074525de5bb741daf382f8d62213f
2011-04-25 16:38:12

Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...

More Articles (1 articles) »
Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related